Antimicrobial resistance among Escherichia coli urinary tract isolates in the United States: A current view provided by electronic surveillance

Infectious Diseases in Clinical Practice

Volumn 10, Issue 2, 2001, Pages 87-92

  Karlowsky, James A ^a   Thornsberry, Clyde ^b   Peterson, Dan E ^a   Mayfield, David C ^a   Sahm, Daniel F ^a  

^a Focus Technologies Incorporated   (United States)

^b Focus Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG EFFICACY; ESCHERICHIA COLI; HUMAN; INTERNET; MAJOR CLINICAL STUDY; UNITED STATES; URINARY TRACT INFECTION;

EID: 0034918193     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-200102000-00004     Document Type: Article

References (8)

1. Diagnosis and treatment of uncomplicated urinary tract infection
2. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women
3. The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women
4. Characteristics of pathogens causing urinary tract infections in hospitals in North America: Results from the SENTRY Antimicrobial Surveillance Program, 1997
5. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women
6. USA resistance patterns among UTI pathogens
7. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the surveillance network database - USA